Company: ARMP
Filing Date: 2025-11-12
Form Type: 8-K
Source: 0001104659-25-110351
Chunk: 0

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-11-12
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02

Results of Operations and Financial Condition.

On November 12, 2025, the Company announced its financial results for the three and nine months ended September 30, 2025, in the press release furnished hereto as Exhibit 99.1.

The information in this Item 2.02 and the attached Exhibit 99.1 is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Item 2.02 and the attached Exhibit 99.1 shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.

Item 9.01Financial Statements and Exhibits.